DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

被引：0
|
作者：
J P B O'Connor
A Jackson
G J M Parker
G C Jayson
机构：
[1] Imaging Science and Biomedical Engineering,Cancer Research UK Department of Medical Oncology
[2] University of Manchester,undefined
[3] Christie Hospital,undefined
来源：
British Journal of Cancer | 2007年 / 96卷
关键词：
angiogenesis inhibitors; biomarkers; clinical trials; dynamic contrast-enhanced magnetic resonance imaging; image analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular disrupting compounds. Evidence of drug efficacy and dose-dependent response has been demonstrated with some angiogenesis inhibitors. This review highlights the critical issues that influence T1-weighted DCE-MRI data acquisition and analysis, identifies important areas for future development and reviews the clinical trial findings to date.
引用
收藏
页码：189 / 195
页数：6
相关论文
共 50 条
  • [11] Utilizing DCE-MRI to monitor the vascular changes induced in a murine cancer model by the novel vascular disrupting drug NPI-2358
    Lloyd, George
    Shen, Y.
    Bertelsen, L.
    Stodkilde-Jorgensen, H.
    Nielsen, T.
    Horsman, Michael
    CANCER RESEARCH, 2009, 69
  • [12] CONVEX ANALYSIS FOR SEPARATION OF FUNCTIONAL PATTERNS IN DCE-MRI: A LONGITUDINAL STUDY TO ANTIANGIOGENIC THERAPY
    Chan, Tsung-Han
    Chen, Li
    Choyke, Peter L.
    Chi, Chong-Yung
    Wang, Yue
    2008 IEEE WORKSHOP ON MACHINE LEARNING FOR SIGNAL PROCESSING, 2008, : 261 - +
  • [13] Permeability Evaluation of Interstitial Cystitis by DCE-MRI of the Bladder
    Wu, D.
    Vo, J.
    North, J.
    Towner, R.
    Hurst, R.
    MEDICAL PHYSICS, 2016, 43 (06) : 3646 - 3646
  • [14] Evaluation of orbital lesions with DCE-MRI: a literature review
    Ang, Terence
    Juniat, Valerie
    Patel, Sandy
    Selva, Dinesh
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (03): : 408 - 416
  • [15] In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor
    Yang, Rui-Meng
    Zou, Yong
    Huang, Dan-Ping
    Lai, Sheng-Sheng
    Xu, Xiang-Dong
    Wei, Xin-Hua
    Chang, Han-Zheng
    Huang, Tong-Kun
    Wang, Li
    Tang, Wen-Jie
    Jiang, Xin-Qing
    ONCOLOGY REPORTS, 2014, 32 (02) : 709 - 715
  • [16] Vascular disrupting and antiangiogenic agents: better together than on their own
    Gomez, Raul
    FERTILITY AND STERILITY, 2013, 100 (05) : 1234 - 1235
  • [17] Antiangiogenic and vascular-disrupting agents in endometriosis:: pitfalls and promises
    Van Langendonckt, Anne
    Donnez, Jacques
    Defrere, Sylvie
    Dunselman, Gerard A. J.
    Groothuis, Patrick G.
    MOLECULAR HUMAN REPRODUCTION, 2008, 14 (05) : 259 - 268
  • [18] Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI
    Zhu, Wenlian
    Kato, Yoshinori
    Artemov, Dmitri
    PLOS ONE, 2014, 9 (01):
  • [19] NOVEL ULTRASOUND AND DCE-MRI ANALYSES AFTER ANTIANGIOGENIC TREATMENT WITH A SELECTIVE VEGF RECEPTOR INHIBITOR
    Watson, Katherine D.
    Hu, Xiaowen
    Lai, Chun-Yen
    Lindfors, Heather A.
    Hu-Lowe, Dana D.
    Tuthill, Theresa A.
    Shalinsky, David R.
    Ferrara, Katherine W.
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2011, 37 (06): : 909 - 921
  • [20] A new algorithm for automatic vascular mapping of DCE-MRI of the breast: Clinical application of a potential new biomarker
    Vignati, A.
    Giannini, V.
    Carbonaro, L. A.
    Bertotto, I.
    Martincich, L.
    Sardanelli, F.
    Regge, D.
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 117 (03) : 482 - 488
12345